What's breaking now, across thousands of outlets.
Beam's first data on a rare disease gene editing therapy: Beam Therapeutics shared initial data from a Phase 1/2 trial of a base editing therapy for glycogen storage disease type Ia ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
WHO: Suspected cholera cases surging in Yemen Suspected cholera cases tripled in three weeks in Yemen, the World Health Organization said Tuesday, warning that the growing disease burden was straining…
(MedPage Today) -- A CT classification system appeared to distinguish patients safe for early discharge from the emergency department after traumatic brain injury (TBI) despite a positive head CT, a…
Any patient with a "grievous and irremediable" illness should, according to guidelines, be told they're eligible to die
Mumbai: The Food and Drug Administration (FDA) has suspended the licences or registrations of three food establishments in Mumbai, including a Domino’s Pizza outlet in Parel, over serious food safety…
Head and neck squamous cell carcinoma (HNSCC) frequently develops in the oral and upper aerodigestive regions following chronic exposure to mutagenic factors such as tobacco, alcohol and betel nut.
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new…
